Article
In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson's disease.
Brain and behavior - 1 Feb 2023
Ho Philip Wing-Lok, Li Lingfei, Liu Hui-Fang, Choi Zoe Yuen-Kiu, Chang Eunice Eun Seo, Pang Shirley Yin-Yu, Malki Yasine, Leung Chi-Ting, Kung Michelle Hiu-Wai, Ramsden David Boyer, Ho Shu-Leong
Abstract excerpt
BACKGROUND: Leucine-rich repeat kinase 2 (LRRK2) mutation is a common genetic risk factor of Parkinson's disease (PD). Presynaptic dysfunction is an early pathogenic event associated with dopamine (DA) dysregulation in striatum of the brain. DA uptake activity of DA uptake transporter (DAT) affects synaptic plasticity and motor and non-motor behavior. Synaptogyrin-3 (SYNGR3) is part of the synaptogyrin family,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
